Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control - Endocrinology Advisor

Endocrinology Advisor

Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control Endocrinology Advisor In patients with non-insulin-treated type 2 diabetes (T2D), self-monitoring of blood glucose (SMBG) failed to improve 1-year glycemic control and health-related quality of life (HRQOL) compared with patients who did not perform SMBG, according to a ...